Controlling the water exchange kinetics of macrocyclic Gd(3+) chelates, a key parameter in the design of improved magnetic resonance imaging (MRI) contrast media, may be facilitated by selecting the coordination geometry of the chelate. The water exchange kinetics of the mono- capped twisted square antiprism (TSAP) being much closer to optimal than those of the mono capped square antiprism (SAP) render the TSAP isomer more desirable for high relaxivity applications. Two systems have been developed that allow for selection of the TSAP coordination geometry in 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-type Gd(3+) chelates, both based upon the macrocycle nitrobenzyl cyclen. In this paper we report investigations into the ...
The need for magnetic resonance imaging (MRI) contrast agents with improved relaxivity maintains the...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The need for MRI contrast agents with improved relaxivity maintains the development of new Gd(III) c...
Water exchange in lanthanide(III) chelates is a key parameter in developing more effective MRI cont...
The square antiprism/twisted square antiprism ratio in LnDOTA-tetraamide chelates is a critical para...
Water exchange in lanthanide(III) chelates is a key parameter in developing more effective MRI contr...
Chemical exchange saturation transfer (CEST) offers many advantages as a method of generating contra...
The bifunctional chelator IB-DOTA has found use in a range of biomedical applications given its abil...
The bifunctional chelator IB-DOTA has found use in a range of biomedical applications given its abil...
[Abstract] The solution dynamics of the Eu(III) complexes of H4dota (1,4,7,10-tetraazacyclododecane-...
LnDOTA-tetraamide chelates (DOTA=1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) have rece...
Lanthanide chelates are effective agents for improving contrast in MR images. Optimizing the relaxat...
[Abstract] Lanthanide complexes with DOTA–tetraglycinate (DOTA-(gly)4) heavily favor the square anti...
Three PEGylated derivatives of 1,4,7,10-tetraazacyclododecane-1-((6-amino)hexanoic)-4,7,10-triacetic...
Lanthanide(III) chelates of DOTA-tetraamide ligands have been an area of particular interest since t...
The need for magnetic resonance imaging (MRI) contrast agents with improved relaxivity maintains the...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The need for MRI contrast agents with improved relaxivity maintains the development of new Gd(III) c...
Water exchange in lanthanide(III) chelates is a key parameter in developing more effective MRI cont...
The square antiprism/twisted square antiprism ratio in LnDOTA-tetraamide chelates is a critical para...
Water exchange in lanthanide(III) chelates is a key parameter in developing more effective MRI contr...
Chemical exchange saturation transfer (CEST) offers many advantages as a method of generating contra...
The bifunctional chelator IB-DOTA has found use in a range of biomedical applications given its abil...
The bifunctional chelator IB-DOTA has found use in a range of biomedical applications given its abil...
[Abstract] The solution dynamics of the Eu(III) complexes of H4dota (1,4,7,10-tetraazacyclododecane-...
LnDOTA-tetraamide chelates (DOTA=1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) have rece...
Lanthanide chelates are effective agents for improving contrast in MR images. Optimizing the relaxat...
[Abstract] Lanthanide complexes with DOTA–tetraglycinate (DOTA-(gly)4) heavily favor the square anti...
Three PEGylated derivatives of 1,4,7,10-tetraazacyclododecane-1-((6-amino)hexanoic)-4,7,10-triacetic...
Lanthanide(III) chelates of DOTA-tetraamide ligands have been an area of particular interest since t...
The need for magnetic resonance imaging (MRI) contrast agents with improved relaxivity maintains the...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The need for MRI contrast agents with improved relaxivity maintains the development of new Gd(III) c...